Taiwanese Biotech Stocks

PharmaEssentia

Market Cap: NT$191.6b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Lotus Pharmaceutical

Market Cap: NT$75.5b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Bora Pharmaceuticals

Market Cap: NT$67.2b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

TTY Biopharm

Market Cap: NT$20.4b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

ScinoPharm Taiwan

Market Cap: NT$17.9b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, the America, and internationally.

YungShin Global Holding

Market Cap: NT$15.3b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Tanvex BioPharma

Market Cap: NT$14.3b

A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.7b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

PharmaEngine

Market Cap: NT$10.5b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Gongwin Biopharm Holdings

Market Cap: NT$9.9b

A clinical-stage biopharmaceutical company, develops anticancer drugs.

Acepodia

Market Cap: NT$8.8b

Operates as a clinical stage biotechnology company.

Adimmune

Market Cap: NT$8.3b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Formosa Laboratories

Market Cap: NT$7.2b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

OBI Pharma

Market Cap: NT$7.2b

A clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally.

Orient Pharma

Market Cap: NT$6.8b

Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

StemCyte International

Market Cap: NT$5.9b

Operates cord blood cell banks in the United States and Taiwan.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.8b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Savior Lifetec

Market Cap: NT$5.7b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

CHO Pharma

Market Cap: NT$5.6b

Engages in research and development of biotechnology in Taiwan.

Medigen Biotechnology

Market Cap: NT$4.5b

A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cell therapy, advanced nucleic acid testing, generic drugs, medical beauty, and vaccine-related products in Taiwan.

Orient EuroPharma

Market Cap: NT$3.9b

A pharmaceutical company, develops and manufactures drugs worldwide.

Nang Kuang Pharmaceutical

Market Cap: NT$3.8b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

BRIM Biotechnology

Market Cap: NT$3.8b

A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.

3D Global Biotech

Market Cap: NT$3.7b

Develops medical materials for human body reconstruction in China.

Energenesis BiomedicalLTD

Market Cap: NT$3.6b

Operates in the biomedicine industry in Taiwan.

Maxigen Biotech

Market Cap: NT$3.6b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

Shine-On BioMedicalLtd

Market Cap: NT$3.4b

Research, develops, and manufactures anti-cancer related drug products.

SunWay Biotech

Market Cap: NT$3.3b

Focuses on professional research and development, and technical material manufacturing and processing business.

Syngen BiotechLtd

Market Cap: NT$3.2b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.2b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Synbio Tech

Market Cap: NT$2.9b

Manufactures and sells human healthcare products and probiotics for animals.

HeXun Biosciences

Market Cap: NT$2.8b

Engages in the research and development of stem cell and treatments in Taiwan.

Allied Biotech

Market Cap: NT$2.5b

Manufactures and sells carotenoids worldwide.

Gwo Xi Stem Cell Applied Technology

Market Cap: NT$2.4b

Develops stem cell medicines for patients with unmet medical needs.

TSH Biopharm

Market Cap: NT$2.1b

Develops and markets pharmaceutical products in Taiwan.

Chunghwa Chemical Synthesis & Biotech

Market Cap: NT$1.9b

Chunghwa Chemical Synthesis & Biotech Co., Ltd.